» Articles » PMID: 39062611

Protein Assemblies in Translesion Synthesis

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2024 Jul 27
PMID 39062611
Authors
Affiliations
Soon will be listed here.
Abstract

Translesion synthesis (TLS) is a mechanism of DNA damage tolerance utilized by eukaryotic cells to replicate DNA across lesions that impede the high-fidelity replication machinery. In TLS, a series of specialized DNA polymerases are employed, which recognize specific DNA lesions, insert nucleotides across the damage, and extend the distorted primer-template. This allows cells to preserve genetic integrity at the cost of mutations. In humans, TLS enzymes include the Y-family, inserter polymerases, Polη, Polι, Polκ, Rev1, and the B-family extender polymerase Polζ, while in only Polη, Rev1, and Polζ are present. To bypass DNA lesions, TLS polymerases cooperate, assembling into a complex on the eukaryotic sliding clamp, PCNA, termed the TLS mutasome. The mutasome assembly is contingent on protein-protein interactions (PPIs) between the modular domains and subunits of TLS enzymes, and their interactions with PCNA and DNA. While the structural mechanisms of DNA lesion bypass by the TLS polymerases and PPIs of their individual modules are well understood, the mechanisms by which they cooperate in the context of TLS complexes have remained elusive. This review focuses on structural studies of TLS polymerases and describes the case of TLS holoenzyme assemblies in action emerging from recent high-resolution Cryo-EM studies.

Citing Articles

Targeting the DNA damage response in cancer.

Federica G, Michela C, Giovanna D MedComm (2020). 2024; 5(11):e788.

PMID: 39492835 PMC: 11527828. DOI: 10.1002/mco2.788.

References
1.
Lemontt J . Mutants of yeast defective in mutation induced by ultraviolet light. Genetics. 1971; 68(1):21-33. PMC: 1212581. DOI: 10.1093/genetics/68.1.21. View

2.
Donigan K, Cerritelli S, McDonald J, Vaisman A, Crouch R, Woodgate R . Unlocking the steric gate of DNA polymerase η leads to increased genomic instability in Saccharomyces cerevisiae. DNA Repair (Amst). 2015; 35:1-12. PMC: 4651834. DOI: 10.1016/j.dnarep.2015.07.002. View

3.
Albertella M, Green C, Lehmann A, OConnor M . A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res. 2005; 65(21):9799-806. DOI: 10.1158/0008-5472.CAN-05-1095. View

4.
Pustovalova Y, Maciejewski M, Korzhnev D . NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain. J Mol Biol. 2013; 425(17):3091-105. DOI: 10.1016/j.jmb.2013.05.029. View

5.
Wojtaszek J, Chatterjee N, Najeeb J, Ramos A, Lee M, Bian K . A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy. Cell. 2019; 178(1):152-159.e11. PMC: 6644000. DOI: 10.1016/j.cell.2019.05.028. View